Heterotopic ossification after total hip arthroplasty: risk factors and prevention

L Vastel1, L Kerboull, P Anract

  • 1Orthopedic Surgery Department, Cochin Teaching Hospital, Paris, France.

Revue Du Rhumatisme (English Ed.)
|May 26, 1998
PubMed

Insights

Heterotopic ossification occurs in over 60% of total hip arthroplasty patients. Routine preventive therapy is recommended, as targeted strategies for specific subgroups appear ineffective.

Area of Science:

  • Orthopedic Surgery
  • Medical Complications

Background:

  • Heterotopic ossification (HO) is a common complication following total hip arthroplasty (THA).
  • Understanding risk factors and incidence is crucial for effective prevention strategies.

Purpose of the Study:

  • To determine the incidence of heterotopic paraarticular ossification after THA.
  • To identify potential risk factors associated with HO development in THA patients.

Main Methods:

  • Retrospective review of 168 consecutive THA procedures performed in 1983.
  • Patients did not receive any prophylactic treatment for HO.
  • Data collected included patient demographics, surgical details, and HO occurrence.

Main Results:

  • HO was observed in 61.3% of patients, with 8.3% experiencing high-grade ossification.
  • Incidence was not significantly influenced by age, gender, joint destruction, or surgical complications.
  • Severe ossification was more prevalent in men and patients operated on by less experienced surgeons.

Conclusions:

  • HO is highly prevalent after THA without preventive therapy.
  • Targeted preventive strategies for specific patient subgroups are likely ineffective.
  • Routine prophylactic therapy for all THA patients is warranted to mitigate HO risk.

Related Concept Videos